高通量定序(HTS) 市场规模、份额和成长分析：按技术、产品、应用、最终用户、工作流程和地区划分－2026-2033 年产业预测

2024年全球高通量定序（HTS）市值为53亿美元，预计将从2025年的57.8亿美元成长到2033年的116.1亿美元。预测期（2026-2033年）的复合年增长率预计为9.1%。

全球高通量定序(HTS) 市场正经历显着成长，这主要得益于快速 DNA 和 RNA 读取技术的进步，这些技术使基因研究得以普及。推动这一成长的关键因素包括成本降低和通量提高，使得全基因测序从一项耗时高成本的长期计划转变为临床和研究领域的标准操作。这种转变对于精准癌症治疗和感染疾病追踪等应用至关重要，从而带动了持续的市场需求。监管政策的明确和基因组分析保险覆盖范围的扩大进一步促进了对临床应用和数据分析的投资。此外，人工智慧的整合透过流程自动化和提高变异解读的准确性，提升了数据分析的效率，为软体和服务引领市场创造了机会。

全球高通量定序(HTS) 市场驱动因素

全球高通量定序(HTS) 市场的主要驱动因素之一是对个人化医疗和基因组研究日益增长的需求。随着我们对基因变异及其对健康影响的理解不断加深，研究人员和医疗保健机构正在利用 HTS 技术开发个人化治疗方法并改善患者预后。此外，遗传疾病盛行率的上升以及对有效诊断工具需求的成长也推动了对先进定序技术的投资。 HTS 在肿瘤学、感染疾病和农业等各领域的应用，透过实现更全面、更有效率的基因分析，进一步加速了市场成长。

全球高通量定序(HTS) 市场的限制因素

全球高通量定序(HTS) 市场的主要限制因素之一是定序技术和必要基础设施的高成本。除了对先进定序设备的初始投资外，小规模实验室和研究机构在维护、试剂和专业人员方面的持续成本也可能非常高昂。这种经济障碍可能会限制资金和资源本就有限的发展中地区采用 HTS 技术。此外，数据分析和解读的复杂性需要专业知识，这可能会进一步限制 HTS 技术的普及，从而阻碍市场成长。

全球高通量定序（HTS）市场趋势

全球高通量定序(HTS) 市场正呈现出显着的趋势，即整合人工智慧驱动的解读生态系统，进而改变基因组分析的模式。相关人员方正日益利用人工智慧和机器学习技术来优化从序列到洞察的工作流程，并提高资料解读的效率和一致性。供应商与生物资讯学专家之间的合作正在推动检验的流程和使用者友善介面的开发，从而最大限度地减少对专业人员的需求。对可互通软体解决方案、标准化本体和云端部署的关注，进一步增强了临床和研究应用的扩充性，并透过订阅平台、分析服务和综合解读解决方案开闢了新的收入来源。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势
• 价值链分析

全球高通量定序(HTS) 市场规模：依技术和复合年增长率划分 (2026-2033)

• 定序方法
  • 定序合成（SBS）
  • 离子半导体定序
  • 单分子即时（SMRT）
  • 奈米孔定序

全球高通量定序(HTS) 市场规模：依产品和复合年增长率 (2026-2033) 划分

• 试剂和耗材
• 装置
• 软体和服务

全球高通量定序(HTS) 市场规模：按应用和复合年增长率 (2026-2033) 划分

• 诊断用途
• 出于研究目的
• 农业用途
• 法医学应用

全球高通量定序(HTS) 市场规模：依最终用户和复合年增长率 (2026-2033) 划分

• 学术和研究机构
• 製药和生物技术公司
• 医院和诊断中心
• 受託研究机构（CRO）

全球高通量定序(HTS) 市场规模：依工作流程及复合年增长率划分 (2026-2033)

• 样品製备
• 定序
• 数据分析

全球高通量定序(HTS) 市场规模及复合年增长率 (2026-2033)

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific
• Agilent Technologies
• Bio-Rad Laboratories
• Merck KGaA
• F. Hoffmann-LA Roche AG
• Abcam
• Cell Signaling Technology
• PerkinElmer
• Sino Biological
• BioGenex
• Illumina
• Pacific Biosciences
• 10x Genomics
• QIAGEN
• Oxford Nanopore Technologies
• Genomatix
• Ginkgo Bioworks
• BGI Group
• Asuragen
• Novogene

结论与建议

Global High-Throughput Sequencing (Hts) Market size was valued at USD 5.3 Billion in 2024 and is poised to grow from USD 5.78 Billion in 2025 to USD 11.61 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The global high-throughput sequencing (HTS) market is experiencing significant growth, propelled by advancements in rapid DNA and RNA reading technologies that have democratized genetic research. Key factors driving this expansion include decreased costs and enhanced throughput, transforming whole-genome sequencing from lengthy, expensive projects into standard practices in clinical and research settings. This evolution is crucial for applications such as precision oncology and infectious disease tracking, leading to sustained market demand. Investment in clinical applications and data analytics further fuels growth, supported by regulatory clarity and payer coverage for genomic profiling. Additionally, the integration of AI enhances data analysis efficiency by automating processes and improving variant interpretation, creating opportunities for software and services to dominate the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global High-Throughput Sequencing (Hts) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global High-Throughput Sequencing (Hts) Market Segments Analysis

Global high-throughput sequencing (hts) market is segmented by technology, product, application, end-user, workflow and region. Based on technology, the market is segmented into Sequencing Methods. Based on product, the market is segmented into Reagents & Consumables, Instruments and Software & Services. Based on application, the market is segmented into Diagnostic Applications, Research Applications, Agricultural Applications and Forensic Applications. Based on end-user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers and Contract Research Organizations (CROs). Based on workflow, the market is segmented into Sample Preparation, Sequencing and Data Analysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global High-Throughput Sequencing (Hts) Market

One of the key market drivers for the Global High-Throughput Sequencing (HTS) Market is the increasing demand for personalized medicine and genomics research. As the understanding of genetic variations and their impact on health expands, researchers and healthcare providers are utilizing HTS technologies to develop tailored therapies and improve patient outcomes. Additionally, the growing prevalence of genetic disorders and the rising need for effective diagnostic tools are propelling investments in advanced sequencing technologies. The integration of HTS in various fields, such as oncology, infectious diseases, and agriculture, further accelerates market growth by enabling more comprehensive and efficient genetic analysis.

Restraints in the Global High-Throughput Sequencing (Hts) Market

One key market restraint for the global high-throughput sequencing (HTS) market is the high cost associated with sequencing technologies and the required infrastructure. The initial investment for advanced sequencing equipment, alongside ongoing expenses for maintenance, reagents, and skilled personnel, can be prohibitively expensive for smaller laboratories and research institutions. This financial barrier may limit the adoption of HTS technologies, particularly in developing regions where funding and resources are already constrained. Additionally, the complexity of data analysis and interpretation necessitates specialized expertise, which can further hinder market growth by restricting access to HTS capabilities.

Market Trends of the Global High-Throughput Sequencing (Hts) Market

The Global High-Throughput Sequencing (HTS) market is witnessing a significant trend towards the integration of AI-enabled interpretation ecosystems, which are transforming the landscape of genomic analysis. Stakeholders are increasingly leveraging artificial intelligence and machine learning technologies to optimize the sequence-to-insight workflow, boosting both efficiency and consistency in data interpretation. Collaborations between vendors and bioinformatics experts are leading to the development of validated pipelines and user-friendly interfaces, minimizing the need for specialized personnel. The focus on interoperable software solutions, standardized ontologies, and cloud-based deployments further enhances scalability for both clinical and research applications, paving the way for new revenue streams through subscription-based platforms, analytics services, and comprehensive interpretation offerings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis

Global High-Throughput Sequencing (HTS) Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Sequencing Methods
  • Sequencing Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT)
  • Nanopore Sequencing

Global High-Throughput Sequencing (HTS) Market Size by Product & CAGR (2026-2033)

• Market Overview
• Reagents & Consumables
• Instruments
• Software & Services

Global High-Throughput Sequencing (HTS) Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostic Applications
• Research Applications
• Agricultural Applications
• Forensic Applications

Global High-Throughput Sequencing (HTS) Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Contract Research Organizations (CROs)

Global High-Throughput Sequencing (HTS) Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sample Preparation
• Sequencing
• Data Analysis

Global High-Throughput Sequencing (HTS) Market Size & CAGR (2026-2033)

• North America (Technology, Product, Application, End-User, Workflow)
  • US
  • Canada
• Europe (Technology, Product, Application, End-User, Workflow)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End-User, Workflow)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End-User, Workflow)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End-User, Workflow)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann- LA Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asuragen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations